Skip to main content
. Author manuscript; available in PMC: 2020 Jan 1.
Published in final edited form as: Curr Med Chem. 2019;26(33):6132–6148. doi: 10.2174/0929867325666180831150259

Figure 4. Evaluation of chemotherapy-loaded exosome nanoparticles.

Figure 4.

A. Total particle yield of exosome-mimetic nanovesicles (NV) and exosomes (EXO) derived from 1 × 107 total cells. B. Cryo-transmission electron micrographs depicting NV with and without doxorubicin (DOX). C. Evaluation of TNF-α-activated HUVEC proliferation following treatment with varying doses of DOX-loaded NV. D. Tumor growth following administration of NV and NV containing DOX (2 μg or 10 μg). Reprint with permissions from ref [53].